Cases 11 - 20 of 1,455
AbbVie Inc. et al v. Alembic Pharmaceuticals Limited et al
as 1:2024cv00405
Plaintiff:
AbbVie Inc., Allergan, Inc., Allergan Sales, LLC and others
Defendant:
Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer HealthCare LLC et al v. Aurobindo Pharma Ltd. et al
as 1:2024cv00399
Plaintiff:
Bayer HealthCare LLC and Meda Pharmaceuticals Inc.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Teva Pharmaceuticals International GmbH et al v. BendaRx USA Corp
as 1:2024cv00395
Plaintiff:
Teva Pharmaceuticals International GmbH, Cephalon, LLC and Eagle Pharmaceuticals Inc.
Defendant:
BendaRx USA Corp
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Azurity Pharmaceuticals, Inc. et al v. Hetero Labs Limited et al
as 1:2024cv00396
Plaintiff:
Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, LLC and Takeda Pharmaceutical Company Limited
Defendant:
Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Intellectual Property GmbH et al v. Prinston Pharmaceutical, Inc.
as 1:2024cv00336
Plaintiff:
Bayer Intellectual Property GmbH, Bayer Pharma AG, Bayer AG and others
Defendant:
Prinston Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. MSN Laboratories Private Ltd. et al
as 1:2024cv00315
Plaintiff:
Pfizer Inc., Global Blood Therapeutics, Inc. and PF PRISM IMB B.V.
Defendant:
MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Azurity Pharmaceuticals, Inc. v. Novitium Pharma, LLC
as 1:2024mc00102
Plaintiff:
Azurity Pharmaceuticals, Inc.
Defendant:
Novitium Pharma LLC
Cause Of Action: 15 U.S.C. § 15 Antitrust Litigation
Rounds v. GlaxoSmithKline, LLC et al
as 1:2024cv00217
Plaintiff:
David Rounds
Defendant:
GlaxoSmithKline, LLC, Pfizer, Inc., Boehringer Ingelheim Pharmaceuticals, Inc. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Notice of Removal
Cusick v. GlaxoSmithKline, LLC et al
as 1:2024cv00215
Plaintiff:
Gaylon Cusick
Defendant:
GlaxoSmithKline, LLC, Pfizer, Inc., Boehringer Ingelheim Pharmaceuticals, Inc. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Notice of Removal
Campion v. Pfizer, Inc. et al
as 1:2024cv00214
Plaintiff:
Renee F. Campion
Defendant:
Pfizer, Inc., Boehringer Ingelheim USA Corporation, Sanofi-Aventis U.S. LLC and others
Cause Of Action: 28 U.S.C. § 1441 Notice of Removal-Personal Injury
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
